raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:637

Full NF2-related schwannomatosis

Synonyms: Full NF2 · Full neurofibromatosis type 2 · Nonmosaic NF2-related schwannomatosis · Nonmosaic neurofibromatosis type 2

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
All ages
Status
active

A rare inherited cancer-predisposing syndrome disorder characterized by the development of multiple schwannomas, meningiomas and ependymoma. Schwannomas typically affect both vestibular nerves but also other cranial and peripheral nerves, leading to tinnitus, hearing loss and balance dysfunction. Intradermal schwannomas and ocular involvement (cataract, retinal hamartoma) are also typical.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFull NF2-related schwannomatosisFull NF2 · Full neurofibromatosis type 2 · Nonmosaic NF2-related schwannomatosis · Nonmosaic neurofibromatosis type 2
frSchwannomatose liée à NF2 germinaleNF2 germinale · NF2 non mosaïque · Neurinome de l'acoustique familial germinal · Neurofibromatose type 2 germinale · Neurofibromatose type 2 non mosaïque · Neurome de l'acoustique familial germinal · Schwannomatose liée à NF2 non mosaïque · Schwannome vestibulaire familial germinal
deSchwannomatose, NF2-assoziierteAkustikusneurinom, bilaterales · NF2 · NF2-bedingte Schwannomatose · Neurofibromatose Typ 2 · Neurofibromatose, zentrale
esSchwannomatosis completa asociada a NF2NF2 · Neurofibromatosis tipo 2 completa · Neurofibromatosis tipo 2 no mosaico
itSchwannomatosi completa correlata a NF2NF2 completa · Neurofibromatosi completa tipo 2 · Neurofibromatosi tipo 2 non in mosaico · Schwannomatosi non in mosaico correlata a NF2
nlVolledige schwannomatose gerelateerd aan NF2Niet-mozaïsche NF2-gerelateerde schwannomatose · Niet-mozaïsche neurofibromatose type 2 · Volledige NF2 · Volledige neurofibromatose type 2
ptSchwanomatose de espectro clínico completo NF2-relacionadaNF2 de espectro clínico completo · Neurofibromatose central · Neurofibromatose tipo 2 não em mosaico · Schwanomatose não em mosaico NF2-relacionada
plNeurofibromatoza typu 2NF2 · Rodzinna szwannoma nerwu przedsionkowego · Rodzinny nerwiak nerwu słuchowego · Rodzinny nerwiak osłonkowy nerwu słuchowego · Pełna schwannomatoza związana z NF2
csNeurofibromatóza, typ 2Bilaterální akustická neurofibromatóza · Centrální neurofibromatóza · NF2
ukПовний NF2-асоційований шванноматозПовний нейрофіброматоз 2 типу · Повний NF2 · Немозаїчний нейрофіброматоз типу 2 · Немозаїчний NF2-асоційований шванноматоз
zh神经纤维瘤病2型NF2
trNörofibromatoz tip 2NF2

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM101000NTBTvalidated
ICD-10Q85.0NTBTattributedvalidated
ICD-11LD2D.11Especificvalidated
MONDO7039Evalidated
MeSHD016518Evalidated
UMLSC0027832Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (5):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
NF2Disease-causing germline mutation(s) inAssessedHGNC:7773ENSG0000018657560737922q12.2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor20301380[PMID]
5

Prevalence and incidence

4 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 0001.7 / 100 000EuropeValue and classValidatedEuropean Medicines Agency 2012[OTHER]
Prevalence at birth1-9 / 100 0003 / 100 000United KingdomValue and classValidated20082463[PMID]
Point prevalence1-9 / 100 0001.78 / 100 000United KingdomValue and classValidated20082463[PMID]
Prevalence at birth1-9 / 100 0002.56 / 100 000FinlandValue and classValidated25354145[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

47 annotations · validated 2020-03-16
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0030430Neuroma
Frequent (79-30%)
HP:0000478Abnormality of the eye
HP:0009589Bilateral vestibular schwannoma
HP:0100963Hyperesthesia
HP:0100009Intracranial meningioma
HP:0002858Meningioma
HP:0002196Myelopathy
HP:0009593Peripheral schwannoma
HP:0007787Posterior subcapsular cataract
HP:0007663Reduced visual acuity
HP:0000407Sensorineural hearing impairment
HP:0010302Spinal cord tumor
Occasional (29-5%)
HP:0001317Abnormal cerebellum morphology
HP:0000587Abnormal optic nerve morphology
HP:0000646Amblyopia
HP:0000618Blindness
HP:0002512Brain stem compression
HP:0100019Cortical cataract
HP:0006824Cranial nerve paralysis
HP:0000651Diplopia
HP:0001260Dysarthria
HP:0002015Dysphagia
HP:0002888Ependymoma
HP:0100014Epiretinal membrane
HP:0010628Facial palsy
HP:0009027Foot dorsiflexor weakness
HP:0001269Hemiparesis
HP:0000238Hydrocephalus
HP:0000953Hyperpigmentation of the skin
HP:0002354Memory impairment
HP:0009831Mononeuropathy
HP:0008069Neoplasm of the skin
HP:0001271Polyneuropathy
HP:0002172Postural instability
HP:0009594Retinal hamartoma
HP:0001250Seizure
HP:0000763Sensory neuropathy
HP:0003474Somatic sensory dysfunction
HP:0100010Spinal meningioma
HP:0000360Tinnitus
HP:0002317Unsteady gait
HP:0000572Visual loss
HP:0031189Wrist drop
Very rare (<4-1%)
HP:0002381Aphasia
HP:0009592Astrocytoma
HP:0009733Glioma
HP:0007968Remnants of the hyaloid vascular system

Run the differential on the 1 obligate / very frequent terms

Annotation source: 20301380[PMID]_26073919[PMID]_28720529[PMID]

7

Sources for this card